On February 3, 2020, Matthew Dallas resigned as a member of the Board of Directors and Audit Committee of Biostage, Inc. Effective as of February 7, 2020, James McGorry resigned from his role as Chief Executive Officer of the Company as well as a member of its Board of Directors, or the Board.
Harvard Apparatus Regenerative Technology Inc.
Equities
HRGN
US09074M2026
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.45 USD | +6.52% | -8.58% | -50.90% |
1st Jan change | Capi. | |
---|---|---|
-50.90% | 32.92M | |
+10.94% | 227B | |
+15.24% | 198B | |
+18.04% | 142B | |
+31.29% | 111B | |
+1.56% | 64.16B | |
+18.26% | 54.1B | |
+5.12% | 51.41B | |
+10.77% | 45.32B | |
+5.54% | 37.32B |
- Stock Market
- Equities
- HRGN Stock
- News Harvard Apparatus Regenerative Technology Inc.
- Biostage, Inc. Announces Executive Changes